Activities of Josefa ANDRÉS BAREA related to 2012/0250(COD)
Plenary speeches (1)
Trade between the Community and third countries in drug precursors (debate)
Shadow reports (1)
REPORT on the proposal for a regulation of the European Parliament and of the Council amending Council Regulation (EC) No 111/2005 laying down rules for the monitoring of trade between the Community and third countries in drug precursors PDF (221 KB) DOC (247 KB)
Amendments (4)
Amendment 22 #
Proposal for a regulation
Recital 6
Recital 6
(6) Medicinal products containing ephedrine or pseudoephedrine should therefore be controlled without impeding their legitimate trade. should also be controlled systematically and in the same way as other scheduled substances, without impeding their legitimate trade. From now on, they should therefore be considered to be substances likely to be scheduled. Or. es (Refers to Article 2(a))
Amendment 23 #
Proposal for a regulation
Recital 7
Recital 7
(7) To this end, any expWith that in mind, a new categorty of medicinal products containing ephedrine or pseudoephedrinescheduled substances should be created to take into account the specific characteristics of medicinal products, the export of which should be preceded by a pre-export notification sent by the competent authorities in the Union to the competent authorities of the country of destination, with the information previously provided by the operator.
Amendment 26 #
Proposal for a regulation
Article 1 – point 1 – point a
Article 1 – point 1 – point a
Regulation (EC) No 111/2005
Article 2 – point a
Article 2 – point a
(a) ‘scheduled substance’: means any substance used for the illicit manufacture of narcotic drugs or psychotropic substances and listed in the Annex, including mixtures and natural products containing such substances, and medicinal products. This excludes natural products and mixtures which contain scheduled substances and which are compounded in such a way that the scheduled substances cannot be easily used or extracted by readily applicable or economically viable means and medicinal products within the meaning of Article 1(2) of Directive 2001/83/EC of the European Parliament and of the Council;"
Amendment 28 #
Proposal for a regulation
Article 1 – point 7
Article 1 – point 7
Regulation (EC) No 111/2005
Article 12 – paragraph 1 – subparagraph 3
Article 12 – paragraph 1 – subparagraph 3